Company profile
Sona Nanotech Inc.
OTC: SNANF · Healthcare · Biotechnology
Canadian filerHQ Halifax, NSReports USD
#1161 of 1,418 Healthcare companies by revenue
EA Score
——FH 22DQ —GM —SS 52
v0.1 · 35/100 weight · pillars only
↑ listing tenure, market scale · ↓ return on assets, Altman-Z
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$2.3M
Employees
8
as of 2026-08-20
Market cap
$28.4M
as of 2026-08-20
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$00 CAD2025
Net income-$2.3M-3.2M CAD2025
Operating income-$2.5M-3.4M CAD2025
Total assets$948.4k1.3M CAD2025
Liabilities$976.0k1.4M CAD2025
Equity-$27.7k-38.8k CAD2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Sona Nanotech Inc.’s revenue?
Sona Nanotech Inc. booked $0 in FY2025 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
Lite Strategy, Inc.49DHigh Sierra Technologies, Inc.——BeyondSpring Inc.34DDefence Therapeutics Inc.——Resverlogix Corp.——EOM Pharmaceuticals Holdings, Inc.——Key facts
CEODavid Andrew Regan
SectorHealthcare
IndustryBiotechnology
HeadquartersHalifax, NS
ExchangeOTC: SNANF
Employees8
IPO date2006-07-27
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.